Cardiac amyloidosis (CA) is caused by extracellular myocardial deposition of amyloid fibrils
that are primary derived either from misfolding of transthyretin (ATTR) or light-chain (AL) …

Cardiac amyloidosis is caused by the extracellular deposition of amyloid fibrils in the heart,
involving not only the myocardium but also any cardiovascular structure. Indeed, this …

Cardiac amyloidosis (CA) is a disease characterized by the deposition of misfolded protein
deposits in the myocardial interstitium. Although advanced CA confers significant morbidity …

Aims To investigate whether left arterial reservoir strain (LASr) could predict new-onset atrial
fibrillation (NOAF) in patients with light-chain-type cardiac amyloidosis (ALCA). Methods and …

Cardiac amyloidosis (CA), caused by the deposition of insoluble amyloid fibrils, impairs
different cardiac structures, altering not only left ventricle (LV) systo-diastolic function but …

Background: In cardiac amyloidosis, the prevalence of thromboembolic events and atrial
fibrillation is higher in transthyretin amyloidosis compared to immunoglobulin light chain …

Background Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy in which abnormally
folded proteins deposit within the myocardium and the atrial walls. While left atrial …

Aims Cardiomyopathy in Fabry disease (FD) is a major determinant of morbidity and
mortality. This study investigates the effects of FD-specific treatment using enzyme …

Cardiac amyloidosis (CA) is related to the aggregation of insoluble fibrous deposits of
misfolded proteins within the myocardium. Transthyretin amyloidosis (ATTR) and …

Cardiac amyloidosis is the most frequent infiltrative disease caused by the deposition of
misfolded proteins in the cardiac tissue, leading to heart failure, brady-and tachyarrhythmia …